Revital-maker Sun Pharma receives USFDA warning over violations at Halol facility

Revital-maker Sun Pharma receives USFDA warning over violations at Halol facility

The letter specifies violations at its Halol facility, with regards to manufacturing of goods.

FPJ Web DeskUpdated: Friday, December 16, 2022, 07:35 PM IST
article-image
Representational image |

Through an exchange filing, Revital maker Sun Pharma has informed that it has received a warning letter from the US Food and Drug Administration.

The letter specifies violations at its Halol facility, with regards to manufacturing of goods, and contents of the letter will be released to the public soon.

RECENT STORIES

ThatWare: Pioneering Advanced SEO Solutions And Driving Digital Success

ThatWare: Pioneering Advanced SEO Solutions And Driving Digital Success

Top Stock Market Institutes and Best Classes in India (2024)

Top Stock Market Institutes and Best Classes in India (2024)

Air India Pilots In For a Treat: Salary Lift-off And New Bonus Schemes Announced; All You Need to...

Air India Pilots In For a Treat: Salary Lift-off And New Bonus Schemes Announced; All You Need to...

'FT Article Is Just Noise From a Long Time Ago', Says Cantor Fitzgerald; Gives Adani Enterprises'...

'FT Article Is Just Noise From a Long Time Ago', Says Cantor Fitzgerald; Gives Adani Enterprises'...

Avenix Fzco Introduces New Expert Advisor Pivozon For Enhanced Forex Trading On EURUSD

Avenix Fzco Introduces New Expert Advisor Pivozon For Enhanced Forex Trading On EURUSD